Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Jun Zhang
Chief executive officer
CN¥700.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 23yrs |
| CEO ownership | 25.6% |
| Management average tenure | 23yrs |
| Board average tenure | 1.3yrs |
Recent management updates
Recent updates
Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd's (SZSE:301130) Weak Earnings Might Be Worse Than They Appear
Nov 02
Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd (SZSE:301130) Is Increasing Its Dividend To CN¥0.26
Jun 07Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd (SZSE:301130) Strong Profits May Be Masking Some Underlying Issues
Apr 29CEO
Jun Zhang (68 yo)
23yrs
Tenure
CN¥700,000
Compensation
Mr. Jun Zhang is Chairman of the Board & GM of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd from December 20, 2001.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & GM | 23yrs | CN¥700.00k | 25.64% CN¥ 534.4m | |
| Financial Director | no data | CN¥125.00k | no data | |
| Director & Deputy GM | 23yrs | CN¥300.00k | 2.58% CN¥ 53.7m | |
| Director & Deputy GM | no data | CN¥300.00k | 1.8% CN¥ 37.5m | |
| Deputy GM | less than a year | no data | no data |
23.0yrs
Average Tenure
63yo
Average Age
Experienced Management: 301130's management team is seasoned and experienced (23 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & GM | 23yrs | CN¥700.00k | 25.64% CN¥ 534.4m | |
| Director & Deputy GM | 23yrs | CN¥300.00k | 2.58% CN¥ 53.7m | |
| Director & Deputy GM | 13.3yrs | CN¥300.00k | 1.8% CN¥ 37.5m | |
| Deputy GM | less than a year | no data | no data | |
| Chairman of the Board of Supervisors | 13.3yrs | no data | 1.11% CN¥ 23.1m | |
| Independent Director | 4.7yrs | CN¥80.00k | no data | |
| Non-independent Director | 1.3yrs | CN¥62.50k | no data | |
| Non-independent Director | 1.3yrs | no data | no data | |
| Non-independent Director | 1.3yrs | no data | no data | |
| Independent Director | 1.3yrs | CN¥33.30k | no data | |
| Independent Director | 1.3yrs | CN¥33.30k | no data | |
| Director | 1.3yrs | no data | no data |
1.3yrs
Average Tenure
59yo
Average Age
Experienced Board: 301130's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 20:58 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|